| Lin, Jiansheng |
REVO, NCT05007145: PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma |
|
|
| Recruiting | 2 | 92 | RoW | PD-1 inhibitor, Albumin-Bound Paclitaxel, Cisplatin, Radiation | Fujian Cancer Hospital, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma | 08/23 | 08/23 | | |
| Chen, Xianqian |
NCT05282095: Effect of HPV Integration on Prognosis of Young Women With CIN2 in China |
|
|
| Recruiting | N/A | 300 | RoW | Follow up | Fujian Maternity and Child Health Hospital | Cervical Intraepithelial Neoplasia, HPV Infection, Virus Integration, HSIL, High Grade Squamous Intraepithelial Lesions | 12/25 | 05/26 | | |
NCT05745597: Prognostic Study of HPV Virus Integration in Women With HSIL |
|
|
| Recruiting | N/A | 1000 | RoW | Follow up | Fujian Maternity and Child Health Hospital | HPV Infection, Virus Integration, HSIL, High Grade Squamous Intraepithelial Lesions | 09/25 | 10/25 | | |
NCT05282745: A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL |
|
|
| Recruiting | N/A | 4000 | RoW | Follow-up | Fujian Maternity and Child Health Hospital | HPV Infection, HSIL, High-Grade Squamous Intraepithelial Lesions, Viral Load | 12/24 | 12/24 | | |
NCT05283239: Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection |
|
|
| Recruiting | N/A | 1000 | RoW | Follow up | Fujian Maternity and Child Health Hospital | HPV Infection, LSIL, Low-Grade Squamous Intraepithelial Lesions, HSIL, High-Grade Squamous Intraepithelial Lesions, Virus Integration | 11/24 | 12/24 | | |
| Xu, Yanchang |
NCT05555901: The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer |
|
|
| Recruiting | 2 | 116 | RoW | Fruquintinib+ chemotherapy, Bevacizumab+ chemotherapy | Fudan University | Metastatic Colorectal Cancer | 09/25 | 09/25 | | |
